Literature DB >> 16488322

Treatment of necrobiosis lipoidica with the tumor necrosis factor antagonist etanercept.

Joshua A Zeichner, Dana W K Stern, Mark Lebwohl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16488322     DOI： 10.1016/j.jaad.2005.11.1042

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  6 in total

Review 1.  Unusual causes of cutaneous ulceration.

Authors:  Jaymie Panuncialman; Vincent Falanga
Journal:  Surg Clin North Am       Date:  2010-12       Impact factor: 2.741

2.  [Successful treatment of a patient with ulcerated necrobiosis lipoidica non diabeticorum with adalimumab].

Authors:  L Leister; A Körber; J Dissemond
Journal:  Hautarzt       Date:  2013-07       Impact factor: 0.751

3.  Ulcerative Necrobiosis Lipoidica: Is There a Place for Anti-TNFα Treatment?

Authors:  Rita Guedes; Inês Leite; Armando Baptista; Natividade Rocha
Journal:  Case Rep Med       Date:  2012-05-23

4.  Miescher's granulomatosis (granulomatosis disciformis chronica et progressiva) in a non-diabetic patient--case report.

Authors:  Beata Bergler-Czop; Ligia Brzezińska-Wcisło; Iwona Rogala-Poborska
Journal:  Diagn Pathol       Date:  2009-08-28       Impact factor: 2.644

5.  Necrobiosis lipoidica diabeticorum: A case-based review of literature.

Authors:  Sunil Kumar Kota; Sruti Jammula; Siva Krishna Kota; Lalit Kumar Meher; Kirtikumar D Modi
Journal:  Indian J Endocrinol Metab       Date:  2012-07

6.  The role of anti-tumour necrosis factor in wound healing: A case report of refractory ulcerated necrobiosis lipoidica treated with adalimumab and review of the literature.

Authors:  Vijay Kumari Sandhu; Afsaneh Alavi
Journal:  SAGE Open Med Case Rep       Date:  2019-10-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.